Characterization of the BclI Polymorphism in the Glucocorticoid Receptor Gene
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Glucocorticoids (GCs) have a major antiproliferative effect, which has led to the use of their synthetic homologs for immunosuppression, treatment of inflammation, and induction of cytotoxicity (1)(2). GCs exert their effect by binding to an intracellular GC receptor (GR), forming a complex that translocates to the nucleus, where GCs then regulate the expression of target genes interacting with promoter GC-responsive elements (1). The different GR forms, resulting from GR gene variability, can affect the regulation of many biological functions, such as hypothalamic-pituitary-adrenal axis regulation and GC responsiveness, thereby underlying susceptibility to many diseases. Indeed, GR mutations have been associated with altered cardiovascular function, metabolic disturbances, and hematologic malignancies (3)(4)(5). Likewise, functional GR variability might affect the therapeutic response to corticosteroid drugs (5). Identification of different GR gene variants may thus be helpful in assessing the role of the GR gene in disease susceptibility or in adjudging predisposition to corticosteroid-associated adverse drug reactions. Several polymorphisms of the GR gene, which might have an impact on GC sensitivity, have been reported (6)(7)(8). Among these, the BclI polymorphism was identified by Southern blotting using human GR cDNA-specific probes (9) that identified two alleles with fragment lengths of 4.5 and 2.3 kb. Several clinical investigations have subsequently suggested that this GR polymorphism is linked to altered GR function (6)(10)(11)(12)(13)(14)(15). An association between the BclI polymorphism and changes in tissue-specific corticosteroid sensitivity, as well as with poor feedback regulation of the hypothalamic-pituitary-adrenal axis, has been reported (6)(10). This was further documented by association of the BclI polymorphism with abdominal obesity (11)(12), insulin resistance (6)(13), and development of an atherogenic profile (6)(14). Similarly, the larger allele of BclI is more frequent in a group of individuals genetically predisposed to develop hypertension (15). The molecular identity of this polymorphism, however, is still unclear, and its analysis has been based on the laborious and time-consuming Southern blot approach, which requires large quantities of DNA and is difficult to apply to large-scale genotyping (6)(10)(11)(12)(13)(14)(15). Here we present the characterization of the BclI polymorphism, as well as the application of two simple genotyping assays for its detection: PCR with restriction fragment length polymorphism (RFLP) analysis and allele-specific oligonucleotide (ASO) hybridization. Using these approaches, we assessed the frequency of this polymorphism in populations of different origin. The BclI site was suggested to be situated in either the first or second intron of the GR gene (6). To search for BclI sites in these gene segments, we used the genomic sequence derived from human chromosome 5 contig (GenBank accession no. NT_029289), on which the exon/intron boundaries were positioned according to the GR mRNA sequence information (GenBank accession no. NM_000176.1) and BLAST search (http://www.ncbi.nlm.nih.gov/BLAST/). The genomic sequence corresponding to the first two introns was analyzed for BclI restriction sites using WebCutter 2.0 software (http://www.firstmarket.com/cutter/cut2.html). We found three BclI sites, one in intron 1 and two in intron 2, whose relative positions to the exon 2/intron 2 boundary are indicated in Fig. 1A . Only the polymorphic BclI site in intron 2, 647 bp from exon/intron junction, produced the fragment sizes corresponding to those obtained by Southern blot experiments (i.e., fragments of 2.2 kb generated in the presence and 3.9 kb in the absence of the BclI site; Fig. 1A ). Although the size of the larger allele would be slightly different from that reported previously (9), no other BclI site produced a fragment of similar size. Molecular characterization and genotyping of the BclI polymorphism in the GR gene. (A), schematic representation of the BclI polymorphic locus. The predicted positions of BclI sites in the first and second introns are given relative to exon 2, whose boundary positions on the chromosome 5 contig (GenBank accession no. NT_029289) is also indicated. The predicted polymorphic BclI site is indicated by bold font. Exons 1 and 2 are represented as gray boxes. The arrows indicate the positions of the PCR amplimers. The expected restriction fragment lengths, obtained using Southern blot, are shown below the schematic. (B), PCR-RFLP analysis of the BclI polymorphism. The pattern of PCR product digestion in lane 1 indicates a homozygous individual for the smaller allele. Lanes 2 and 3 contain samples from heterozygous individuals, and lane 4 contains a sample from an individual homozygous for the larger allele. (C), nature of the underlying DNA variant. Four individuals were sequenced: two homozygous for the smaller allele (lanes
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Huizenga, N. A. T. M. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.144 · Cited by 265
Cited by
Salivary cortisol as a biomarker in stress research
Hellhammer, D. H., Wüst, S., & Kudielka, B. M. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.10.026 · Cited by 1,925
Role of stress in the pathogenesis of the metabolic syndrome
Rosmond, R. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.05.007 · Cited by 516
Corticosteroid receptor polymorphisms: Determinants of vulnerability and resilience
DeRijk, R. H., & de Kloet, E. R. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.072 · Cited by 184
Rosmond, R., & Holm, G. (2008) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4572.2008.00008.x · Cited by 41
El-Hage, W., Phillips, M. L., Radua, J., Gohier, B., Zelaya, F. O., Collier, D. A., & Surguladze, S. A. (2013) · Molecular Psychiatry · doi:10.1038/mp.2011.145 · Cited by 24
Metadata
- Authors
- Fleury, I., Beaulieu, P., Primeau, M., Labuda, D., Sinnett, D., & Krajinovic, M.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-09-01
- Volume
- 49
- Issue
- 9
- Pages
- 1528-1531
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2098413209
- Cited by
- 71
- References
- 1
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterization of the BclI Polymorphism in the Glucocorticoid Receptor Gene. https://app.cochat.ai/papers/10.1373/49.9.1528
- The paper
- Fleury, I., Beaulieu, P., Primeau, M., Labuda, D., Sinnett, D., & Krajinovic, M. (2003). Characterization of the BclI Polymorphism in the Glucocorticoid Receptor Gene. Clinical Chemistry. https://doi.org/10.1373/49.9.1528
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.